20
Apr
2015
Hungry for Cash, Academia Reaches For a Bigger Piece of Biotech Action
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account. 
Share:
15
Apr
2015
Who Should Biotech Pros Follow on Twitter?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
13
Apr
2015
The Big Boys Love Kendall Square. Let’s Hope They Don’t Squeeze The Life Out of It
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Apr
2015
Which Big Public Investors Are ‘Crossing Over’ Into the Private Arena?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Apr
2015
Baseball Meets Biotech, Where Hope Springs Eternal
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
Apr
2015
Will We Just Give Up on Federal Funding for Research? I Sure Hope Not
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
3
Apr
2015
Sarepta’s Controversial CEO is Out, But Duchenne Muscular Dystrophy R&D is Rising
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
30
Mar
2015
Cancer Combos Are the Way Forward. Will Drugmakers Put Patients First?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
26
Mar
2015
See the Photos: Timmerman Report West Coast Launch Party
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
24
Mar
2015
Come to Pfizer Cambridge for the East Coast Launch Party
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
23
Mar
2015
Company Subscriptions: You Asked, and You Will Get
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
23
Mar
2015
Salaries are Inching Up in the Biotech Boom, Not Booming
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
20
Mar
2015
NASH is the Next Monster Pharmaceutical Market. Here Are The Players
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
18
Mar
2015
Third Rock’s Revolution Medicines Tears Apart Antifungals, Atom By Atom
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Mar
2015
The Top 20 Early-Stage Biotech Investors (And 2 Resuscitated By the Boom)
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
13
Mar
2015
Ember Therapeutics, After Shutting Down, Pools IP With Mariel
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
12
Mar
2015
Antibiotic R&D Is Getting More Attention. Who’s Doing What?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Mar
2015
2015 Power Rankings: Biotech Investment Banks
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Mar
2015
Esperion Jockeys For Place Between Statins and the Next Big Class of Heart Drugs
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
3
Mar
2015
Come Celebrate at the Timmerman Report Launch Party
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share: